DYAI (Dyadic International Inc) יחס שווי שוק לשווי בספרים

The Dyadic International (DYAI) price chart demonstrates the asset's dynamics, with its value fixed at -6.00. Dyadic International is implementing a unique gene expression system for the ultra-fast synthesis of antibodies and vaccines. Its proprietary laboratories in Florida focus on R&D, while product manufacturing is delegated to contractors. The business model relies on selling patents to global behemoths, generating revenue through royalties without the overhead of owning factories.

During periods of market volatility, investors seek to determine the actual protection of their capital. The logistics reliability of Dyadic International (DYAI) in delivering critical vaccine components minimizes operational risks. The market-to-book ratio indicates the market premium over the company's net assets. By analyzing the dynamics of the market value to book value ratio, one can assess the degree of business overvaluation. This allows for balancing the downside risk against the potential for value growth.